Article Sidebar
Published:
Apr 8, 2024DOI:
10.4314/ahs.v24i1.25Keywords:
Article Details
While African Health Sciences has been freely accessible online there have been questions on whether it is Open Access or not. We wish to clearly state that indeed African Health Sciences is Open Access. There are key issues regarding Open Access needing clarification for avoidance of doubt:
- 1. Henceforth, papers in African Health Sciences will be published under the CC BY (Creative Commons Attribution License) 4.0 International. See details on https://creativecomons.org/)
- 2. The copyright owners or the authors grant the 3rd party (perpetually and in advance) the right to disseminate, reproduce, or use the research papers in part or in full, format/medium as long as:
- No substantive errors are introduced in the process
- Attribution of authorship and correct citation details are given
- The referencing details are not changed.
Should the papers be reproduced in part, this must be clearly stated.
- 3. The papers will be freely and universally accessible online in an easily readable format such as XML in at least one widely recognized open access repository such as PUBMED CENTRAL.
B. ABRIDGED LICENCE AGREEMENT BETWEEN AUTHORS AND African Health Sciences
I submitted my manuscript to African Health Sciences and would like to affirm that:
1.0 I am authorized by my co-authors to enter into these arrangements.
2.0 I guarantee, on behalf of self and co-authors:
- That the paper is original, and has not been published in any other peer-reviewed journal; nor is it under consideration by other journal (s). It does not infringe existing copyright or any other person’s rights
- That we are/I am the sole author(s) of the paper and with authority to enter into this agreement. My granting rights to African Health Sciences is not in breach of any other obligation
- That the paper contains nothing unlawful, or libelous. Nor anything that would constitute a breach of contract, confidence or commitment given to secrecy, if published
- That I/we have taken care to ensure the integrity of the article.
3.0 I and all co-authors, agree that the paper, if accepted for publication, shall be licensed under the Creative Commons Attribution License 4.0. (see https://creativecommons.org/)
Main Article Content
Trazodone-induced parkinsonism in a middle-aged male: A case report
Abstract
Introduction: Trazodone is an antidepressant agent approved for treating major depressive disorders and is also prescribed for
insomnia due to its sedative effect. In a few cases, trazodone was associated with parkinsonism. Herein, we describe a case of
parkinsonism after a brief exposure to a moderate dose of trazodone.
Objective: To describe a case of a patient with trazodone-induced parkinsonism in which the diagnosis was suspected after the
exclusion of other common and serious causes.
Methods: A case report of trazodone-induced parkinsonism.
Clinical Case: A 58-year-old male with sleeping problems was prescribed trazodone 50 mg daily at bedtime. The subject doubled
the dosage without medical advice a week later. After 14 days of trazodone treatment, he started to experience difficulty in
moving his upper limbs and recurrent falling. Neuroimaging, electrodiagnostic studies, and laboratory exams were unremarkable.
Trazodone was discontinued, and the patient fully recovered. Noteworthy, the patient developed a recurrence of the motor
symptoms with trazodone-rechallenge.
Conclusion: Our case showed reversibly induced parkinsonism after a short intake of a moderate dose of trazodone which was
prescribed for insomnia. The patient had a complete recovery after trazodone withdrawal. Noteworthy, the symptoms recurred
upon trazodone-rechallenge.
Keywords: Trazodone; triazolopyridine; parkinsonism; movement disorder; drug-induced.
